{"id":71901,"date":"2022-01-18T00:00:00","date_gmt":"2022-01-18T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2022\/01\/18\/guideline-issued-for-external-beam-rt-in-primary-liver-cancers\/"},"modified":"2022-01-20T16:11:42","modified_gmt":"2022-01-20T16:11:42","slug":"guideline-issued-for-external-beam-rt-in-primary-liver-cancers","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/01\/18\/guideline-issued-for-external-beam-rt-in-primary-liver-cancers\/","title":{"rendered":"Guideline Issued for External Beam RT in Primary Liver Cancers"},"content":{"rendered":"<h3>\n<p>EBRT strongly recommended as potential first-line therapy for patients with HCC confined to liver who are not candidates for curative therapy<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, Jan. 18, 2022 (HealthDay News) &#8212; In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the January issue of <em>Practical Radiation Oncology<\/em>, recommendations are presented for the use of external beam radiation therapy (EBRT) for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC).<\/p>\n<p>Smith Apisarnthanarax, M.D., from the University of Washington in Seattle, and colleagues developed a guideline to address five key questions focused on the indications, techniques, and outcomes of EBRT in HCC and IHC.<\/p>\n<p>The researchers strongly recommend EBRT as a potential first-line treatment for patients with HCC confined to the liver who are not candidates for curative therapy; as consolidative therapy after incomplete response following liver-directed therapies; and as a salvage option for local recurrence. For patients with liver-confined multifocal or unresectable HCC or those with macrovascular invasion, EBRT is conditionally recommended, sequenced with systemic or catheter-based therapies. For symptomatic primary HCC and\/or macrovascular tumor thrombi, palliative EBRT is conditionally recommended. In carefully selected patients, EBRT is conditionally recommended as a bridge to transplant or before surgery. Consolidative EBRT with or without chemotherapy should be considered for patients with unresectable IHC. For resected IHC with high-risk features, adjuvant EBRT is conditionally recommended.<\/p>\n<p>&#8220;We feel that this guideline is an important milestone in the management of primary liver cancers, as we hope to provide practitioners and the public with a systematic and evidence-based foundation of where EBRT might fit into the overall complex picture of treating these challenging cases,&#8221; Apisarnthanarax said in a statement.<\/p>\n<p>Several authors disclosed financial ties to industry.<\/p>\n<p><a href=\"https:\/\/www.practicalradonc.org\/article\/S1879-8500(21)00233-2\/fulltext\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EBRT strongly recommended as potential first-line therapy for patients with HCC confined to liver who are not candidates for curative therapy<\/p>\n","protected":false},"author":6,"featured_media":72061,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-71901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/71901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=71901"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/71901\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/72061"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=71901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=71901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=71901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}